Cloudbreak Pharma
HK$1.1950
0
+HK$0.04+3.02%Wednesday 07:28
Statistics
Day High
1.21
Day Low
1.165
52W High
9.58
52W Low
0.9
Volume
18,500
Avg. Volume
318,969
Mkt Cap
166.41M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Financials
-991.3%Profit Margin
Unprofitable77.67MRevenue
-769.98MNet Income
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Cloudbreak Pharma Inc., a clinical-stage ophthalmology biotechnology company, researches and develops ophthalmic drugs for chronic eye diseases. The company develops CBT-001, which is in Phase 3 clinical trial for treating pterygium; CBT-009, a topical formulation of atropine that is in Phase 1/2 study indicated for the treatment of juvenile myopia; CBT-004, a VEGF receptor inhibitor, which is in Phase 2 clinical trial for treating vascularised pinguecula; and CBT-006, a cholesterol dissolving molecule containing the active pharmaceutical ingredient of hydroxypropyl beta-cyclodextrins that is in Phase 2 clinical trial for the treatment of meibomian gland dysfunction associated dry eye disease. It also develops CBT-199 and CBT-145 for the treatment of presbyopia, a condition caused by an age-related process; CBT-007, an eye drop for enhancing success rate of glaucoma filtration surgery; and CBT-011, an antibody-drug-synergism conjugate for the treatment of diabetic macular edema. The company was founded in 2015 and is headquartered in Irvine, California.
Show More
CEO
Jinsong Ni
Employees
61
Country
United States
ISIN
KYG2215S1084
Listings
0 Comments
Share your thoughts
FAQs
What is Cloudbreak Pharma stock price today?▼
The current price of 2592.HK is HK$1.20 HKD — it has increased by +3.02% in the past 24 hours. Watch Cloudbreak Pharma stock price performance more closely on the chart.
What is Cloudbreak Pharma stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Hong Kong Exchange exchange Cloudbreak Pharma stocks are traded under the ticker 2592.HK.
Is Cloudbreak Pharma stock price growing?▼
2592.HK stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Cloudbreak Pharma has showed a -74.02% decrease.
What is Cloudbreak Pharma market cap?▼
Today Cloudbreak Pharma has the market capitalization of 166.41M
What is Cloudbreak Pharma revenue for the last year?▼
Cloudbreak Pharma revenue for the last year amounts to 77.67M HKD.
What is Cloudbreak Pharma net income for the last year?▼
2592.HK net income for the last year is -769.98M HKD.
How many employees does Cloudbreak Pharma have?▼
As of November 3, 2026, the company has 61 employees.
In which sector is Cloudbreak Pharma located?▼
Cloudbreak Pharma operates in the Health & Wellness sector.
When did Cloudbreak Pharma complete a stock split?▼
Cloudbreak Pharma has not had any recent stock splits.
Where is Cloudbreak Pharma headquartered?▼
Cloudbreak Pharma is headquartered in Irvine, United States.